Epigenetic therapy in a rare ovarian cancer - A double-edged sword Correspondence

  

Authors:	Hsu, C.; Konner, J. A.; Gounder, M. M.
Title:	Epigenetic therapy in a rare ovarian cancer - A double-edged sword
Keywords:	adult; clinical article; gene mutation; overall survival; sequence analysis; genetics; constipation; case report; drug efficacy; genetic analysis; letter; cell proliferation; cytoreductive surgery; ovarian neoplasms; metastasis; progression free survival; ovary cancer; vomiting; calcium blood level; dna methylation; carcinogenesis; myelodysplastic syndrome; gene rearrangement; immunotherapy; epigenetics; epigenesis, genetic; ovary tumor; ovary carcinoma; gene therapy; hematopoiesis; drug therapy; hematoma; genetic epigenesis; brain hemorrhage; lethality; rankin scale; chromatin assembly and disassembly; platelet count; randomized controlled trial (topic); phase 2 clinical trial (topic); phase 3 clinical trial (topic); drug comparison; humans; human; female
Journal Title:	New England Journal of Medicine
Volume:	391
Issue:	8
ISSN:	0028-4793
Publisher:	Massachusetts Medical Society
Date Published:	2024-08-22
Start Page:	770
End Page:	772
Language:	English
DOI:	10.1056/NEJMc2407971
PUBMED:	39167815
PROVIDER:	scopus
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85201886022&doi=10.1056%2fNEJMc2407971&partnerID=40&md5=0845a762d5469807c938be9e37b04655
Notes:	Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/218179